Industrial Research World

  According to a study,  Cancer Stem Cells Market  by Research Dive, the global market will   surpass $1,722.7 million by 2026 . Rising number of cancer patients, coupled with the latest advancements in cancer stem cells will upsurge the global market by the  year 2026. Rising tension of cancer all over the world is one of the significant factor which drives the growth of cancer stem cells market. According to the World Health Organization (WHO), one out of six deaths are occurs due to cancers such as breast cancer, lungs cancer and others. The causes for the growing cases of cancer patients include urban air pollution, sexually transmitted HPV infection, alcohol consumption, poor intake of fruit and vegetables. Moreover, late-stage presentation and inaccessible diagnosis are the common factor which increases risk of cancer. On the other hand, stem cell research has capability to manufacture different types of medicines for diseases along with finding drugs that can be used for treatme

  At this moment in time, the whole world is in havoc owing to the abrupt outburst of COVID-19 pandemic. However, this pandemic situation has created a positive impact on the global cancer stem cells market. A latest report published by Research Dive reveals that the global cancer stem cells market is anticipated to gather $1,898.3 billion by 2026, rising at a growth rate of 11.8% from 2019 to 2026. The report segments the global market into application, cancer forms, and region. The report provides comprehensive analysis of the impact of COVID-19 on the key drivers, opportunities, limitations, key segments, and top players of the global market.  Factors Impelling the Market Growth amidst COVID-19 Crisis Regardless of the outbreak of COVID-19 pandemic, government bodies all over the world are hugely   investing on research & development activities to enhance the use of cancer stem cells   in the cancer treatments. Additionally, the development of stem cells for stem line banking an